Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Fenbendazole belongs to a drug class that disables a cell's internal scaffolding. Here is what the tubulin research actually shows—and does not show.
Why some medicines demand an empty stomach and others need a meal comes down to chemistry, not habit. Understanding the reason helps a prescription actually work.
At low, sub-antimicrobial doses, doxycycline works as an anti-inflammatory agent rather than an antibiotic. Here is what the research actually shows for rosacea and related skin conditions.
A sober look at fenbendazole's laboratory and animal cancer studies — what has been shown, what hasn't, and what remains unknown in humans.
Ivermectin earned its creators a Nobel Prize in 2015 — then the same establishment that celebrated it tried to bury it. Here's the full story.
In 2016, Joe Tippens was given three months to live with small-cell lung cancer. His recovery with fenbendazole sparked a global research movement.
HCQ has been prescribed safely since 1955. Lupus and rheumatoid arthritis patients have taken it for decades. The 2020 controversy ignored all of this.
Mebendazole — a cheap, widely available antiparasitic — is showing remarkable results in cancer research labs. Here's why it isn't on your oncologist's radar.
The Front Line COVID-19 Critical Care Alliance doctors risked their careers to share early treatment protocols. Here's what they recommended and why.